Corrigendum to “Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database” [Eur J Canc 125, (January 2020) 153–163]
Titel:
Corrigendum to “Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database” [Eur J Canc 125, (January 2020) 153–163]
Auteur:
Delanoy, Nicolas Hardy-Bessard, Anne-Claire Efstathiou, Eleni Le Moulec, Sylvestre Basso, Umberto Birtle, Alison Thomson, Alastair Krainer, Michael Guillot, Aline De Giorgi, Ugo Hasbini, Ali Daugaard, Gedske Bahl, Amit Chowdhury, Simon Caffo, Orazio Beuzeboc, Philippe Spaeth, Dominique Eymard, Jean-Christophe Fléchon, Aude Alexandre, Jerome Helissey, Carole Butt, Mohamed Priou, Frank Lechevallier, Eric Deville, Jean-Laurent Gross-Goupil, Marine Morales, Rafael Thiery-Vuillemin, Antoine Gavrikova, Tatiana Barthélémy, Philippe Sella, Avishay Fizazi, Karim Ferrero, Jean-Marc Laguerre, Brigitte Thibault, Constance Hans, Sophie Oudard, Stéphane